Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Chinês | WPRIM | ID: wpr-312387

RESUMO

<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of endoscopic mucous resection with transparent cap (EMR-Cap) and endoscopic multi-band mucosectomy (MBM) in the treatment of early esophageal cancer and precancerous lesion.</p><p><b>METHODS</b>A retrospective study was performed to review 30 EMR-Cap cases from December 2008 to December 2009 and 32 MBM cases from January 2010 to January 2011 of early esophageal cancer and precancerous lesions. The differences between these two techniques in efficacy, safety, and cost were compared.</p><p><b>RESULTS</b>In EMR-Cap group, the median resection time was 26(10-56) min and median procedure time was 43(22-81) min, significantly longer than those in MBM group [10(7-18) min and 32(28-45) min, P=0.036 and 0.038, respectively]. There were no significant differences between the two groups in total thickness and depth of resected lesions (P>0.05). In EMR-Cap group, the median cost was significantly higher than that of MBM group [(5466±354) vs. (4014±368) RMB, P=0.008)].</p><p><b>CONCLUSIONS</b>EMR-Cap and MBM are minimally invasive, safe and effective methods in the treatment of early esophageal cancer and precancerous lesions. Compared to the EMR-Cap, MBM is simple with shorter treatment time and lower cost.</p>


Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Endoscopia , Métodos , Neoplasias Esofágicas , Cirurgia Geral , Seguimentos , Mucosa , Cirurgia Geral , Lesões Pré-Cancerosas , Cirurgia Geral , Estudos Retrospectivos , Resultado do Tratamento
2.
Zhonghua zhong liu za zhi ; (12): 536-540, 2009.
Artigo em Chinês | WPRIM | ID: wpr-293072

RESUMO

<p><b>OBJECTIVE</b>To evaluate the value of transbronchial needle aspiration (TBNA) combined with transesophageal endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in the diagnosis of mediastinal and pulmonary hilar lesions as well as in the lymph node staging (N staging) of lung cancer.</p><p><b>METHODS</b>129 patients with mediastinal and pulmonary hilar lesions underwent either TBNA or EUS-FNA with cytological needle aspiration. The samples obtained from TBNA or EUS-FNA were examined by both cytologiy and histopathology.</p><p><b>RESULTS</b>Of the 129 patients, 59 underwent TBNA and 70 EUS-FNA. The diagnostic rate were 84.7% (50/59) by TBNA and 94.3% (66/70) by EUS-FNA, resepectively. The diagnosis of 116 (89.9%) patients were confirmed by either TBNA or EUS-FNA. The pathological and cytological diagnostic rates were 92.2% (107/116) and 88.0% (102/116), resepectively. The diagnostic rate was elevated by 8.4% (9/107) through pathological examination. The histological classification rates by cytological and pathological examination were 73.8% (76/116) and 89.3% (92/103), respectively. The diagnostic rate of histological classification was elevated by 35.5% (27/76) through pathological examination.</p><p><b>CONCLUSION</b>The combination of TBNA and EUS-FNA can improve the diagnostic rate for wider mediastinal and pulmlonary hilar lesions. Pathological examination of the samples obtained from the TBNA and EUS-FNA can elevate not only the rate of diagnosis but also the rate of histological classification.</p>


Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Adenocarcinoma , Diagnóstico por Imagem , Patologia , Biópsia por Agulha Fina , Métodos , Biópsia por Agulha , Carcinoma de Células Escamosas , Diagnóstico por Imagem , Patologia , Endossonografia , Métodos , Neoplasias Pulmonares , Diagnóstico por Imagem , Patologia , Linfonodos , Diagnóstico por Imagem , Patologia , Metástase Linfática , Neoplasias do Mediastino , Diagnóstico por Imagem , Patologia , Mediastino , Estadiamento de Neoplasias , Carcinoma de Pequenas Células do Pulmão , Diagnóstico por Imagem , Patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA